THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.

Abbreviations

Abbreviations

GMB

Adult glioblastoma

pHGG

Paediatric high-grade glioma

UNCAN

EU initiative for understanding cancer

MRI

Magnetic resonance imaging 

SOC

Standard of care

I/O

Immuno-oncology

TTF

Tumour treating fields

Discover the Understanding (tumour-host interactions) Cluster projects through our video and brochure

The Understanding (tumour-host interactions) Cluster brings together six EU-funded projects – ARTURO, GLIOMATCH, HIT-GLIO, MULTIR, SPACETIME and THRIVE – to advance research on cancer development and contribute to Europe’s Beating Cancer Plan. Read more about the cluster and its project on our dedicated page.

About the U-THI-Clust

Joint communication and dissemination

As part of the Communication and Dissemination working group, we’ve created joint cluster materials. Explore our new brochure and introductory video to learn more about the cluster’s objectives, collaboration areas and joint impact. 

Introductory video

Explore all videos on our dedicated page.

All videos

Cluster brochure (preview)

A
B
C

Download the full brochure and other project materials on our dedicated page.

All materials

Follow GLIOMATCH on LinkedIn and Facebook for more information on brain tumour research and updates on our milestones towards improving the clinical outcomes of GBM and pHGG.

For more pictures from our events, visit our photo gallery.

More Posts

GLIOMATCH results contribute to new EIC-funded project GLIOBREAK

Results from GLIOMATCH are supporting the newly funded EIC Transition project GLIOBREAK, coordinated by Beactica Therapeutics and with the involvement of KU Leuven. The project will advance BEA-17, a first-in-class LSD1–CoREST degrader, towards clinical readiness, including IND-enabling studies and regulatory submission.

International Childhood Cancer Day 2026

On International Childhood Cancer Day, GLIOMATCH highlights the urgent need for research into paediatric high-grade gliomas (pHGGs), rare and aggressive brain tumours affecting children. With a median survival of just over one year and no curative treatment available, collaborative research efforts are essential to better understand the disease, develop dedicated models, and tailor therapies that improve outcomes and quality of life for young patients and their families.

International Day of Women and Girls in Science 2026

GLIOMATCH celebrates the women researchers across its consortium whose expertise and commitment drive the development of tailored immunotherapies for malignant brain tumours, marking the International Day of Women and Girls in Science 2026.